Risk Assessment Instruments in Clinical Practice

被引:20
|
作者
Cote, Gilles [1 ,2 ]
Crocker, Anne G. [3 ,4 ]
Nicholls, Tonia L. [5 ,6 ]
Seto, Michael C. [7 ,8 ]
机构
[1] Inst Philippe Pinel, Res Ctr, Montreal, PQ H1C 1H1, Canada
[2] Univ Quebec Trois Rivieres, Dept Psychol, Trois Rivieres, PQ GA9 5H7, Canada
[3] McGill Univ, Dept Psychiat, Montreal, PQ, Canada
[4] Douglas Mental Hlth Univ Inst, Res Ctr, Montreal, PQ, Canada
[5] British Columbia Forens Psychiat Serv Commiss, Port Coquitlam, BC, Canada
[6] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada
[7] Royal Ottawa Hlth Care Grp, Ottawa, ON, Canada
[8] Univ Toronto, Dept Psychiat, Toronto, ON, Canada
基金
加拿大健康研究院;
关键词
risk assessment; clinical practice; forensic; mental health; HCR-20; VIOLENCE RISK; PSYCHOPATHY CHECKLIST; PSYCHIATRIC-PATIENTS; ASSESSMENT SCHEME; PCL-R; HCR-20; VALIDITY; SAMPLE; PREDICTION; SECURITY;
D O I
10.1177/070674371205700407
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: To determine whether the items in one of the most widely validated instruments of violence risk assessment, the Historical Clinical Risk Management-20 (HCR-20), are used in review board hearings to assess the risk of violence by people found Not Criminally Responsible on account of Mental Disorder (NCRMD). Method: This study was conducted from October 2004 to August 2006 in Quebec's sole forensic psychiatric hospital and 2 large civil psychiatric hospitals designated for the care of people declared NCRMD in the Montreal metropolitan area. The risk assessments presented by clinicians at annual review board hearings and the boards' rationale for the release or detention of people found NCRMD were contrasted with the risk assessments conducted by the research team using the HCR-20. The final sample was comprised of 96 men. Results: Very few of the risk factors identified by prior research (HCR-20 items) were mentioned in the hearing process, whether in clinical reports, discussions during the hearing, or in the disposition justification. Conclusions: The findings confirm that there remains a significant gap between research evidence and risk assessment practice.
引用
收藏
页码:238 / 244
页数:7
相关论文
共 50 条
  • [41] Commentary: Incorporation of competence instruments into clinical practice
    Mankad, MV
    Brakel, SJ
    Wilson, RM
    JOURNAL OF THE AMERICAN ACADEMY OF PSYCHIATRY AND THE LAW, 2002, 30 (04): : 483 - 485
  • [42] A comparison of clinical practice guideline appraisal instruments
    Graham, ID
    Calder, LA
    Hébert, PC
    Carter, AO
    Tetroe, JM
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2000, 16 (04) : 1024 - 1038
  • [43] ROUTINE QUALITY ASSESSMENT OF CANCER CARE, THROUGH INFORMATION TECHNOLOGY INSTRUMENTS INCORPORATED INTO CLINICAL PRACTICE
    Galligioni, E.
    Forti, S.
    Berloffa, F.
    Caffo, O.
    Ferro, A.
    Eccher, C.
    Caldara, A.
    Murgia, V
    Soini, B.
    Frisinghelli, M.
    ANNALS OF ONCOLOGY, 2009, 20
  • [44] Novel cardiovascular risk-assessment metrics and absolute risk assessment: future role in clinical practice?
    Kalhan, Atul
    Rees, Alan
    CURRENT OPINION IN LIPIDOLOGY, 2014, 25 (04) : 321 - 323
  • [45] Use of Fracture Risk Assessment Tool in clinical practice and Fracture Risk Assessment Tool future directions
    Zerikly, Rahfa
    Demetriou, Emily Wood
    WOMENS HEALTH, 2024, 20
  • [46] Choosing Assessment Instruments for Bulimia Practice and Outcome Research
    Sandberg, Katie
    Erford, Bradley T.
    JOURNAL OF COUNSELING AND DEVELOPMENT, 2013, 91 (03): : 367 - 379
  • [47] Assessment of clinical practice
    Bradshaw, P
    NURSE EDUCATION TODAY, 2000, 20 (03) : 254 - 254
  • [48] Cardiovascular risk assessment in daily clinical practice: when and how to use a risk score
    Panattoni, Germana
    Desimone, Pietro
    Toto, Federica
    Meringolo, Federica
    Jacomelli, Ilaria
    Rebecchi, Marco
    Cicogna, Francesco
    Calo, Leonardo
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2025, 27 : i16 - i21
  • [49] Risk Assessment in Clinical Practice - Results of the International Risk Survey (IRiS) From Germany
    Rettenberger, Martin
    Eher, Reinhard
    Desmarais, Sarah L.
    Hurducas, Cristina
    Arbach-Lucioni, Karin
    Condemarin, Carolina
    Dean, Kimberlie
    Doyle, Michael
    Folino, Jorge O.
    Godoy-Cervera, Veronica
    Grann, Martin
    Ho, Robyn Mei Yee
    Large, Matthew M.
    Pham, Thierry H.
    Nielsen, Louise Hjort
    Rebocho, Maria Francisca
    Reeves, Kim A.
    de Ruiter, Corine
    Seewald, Katharina
    Singh, Jay P.
    DIAGNOSTICA, 2017, 63 (01): : 2 - 14
  • [50] Benefit/risk assessment of SERM therapy - Clinical trial versus clinical practice settings
    Costantino, JP
    SELECTIVE ESTROGEN RECEPTOR MODULATORS (SERMS), 2001, 949 : 280 - 285